CBLL
CeriBell, Inc. (NASDAQ)
Healthcare — Medical Devices
CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting. The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly transmit EEG signals; and Clarity, an AI-powered seizure detection algorithm. In addition, it operates an EEG portal, which enables real-time remote access to a patient's EEG data. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. CeriBell, Inc. was incorporated in 2014 and is headquartered in Sunnyvale, California.
Price History
Fundamentals
| Market Cap | $758.85M |
| P/E Ratio (TTM) | - |
| Forward P/E | -18.21 |
| EPS (TTM) | $-1.62 |
| Dividend Yield | - |
| Profit Margin | -63.51% |
| Revenue Growth | 29.30% |
| ROE | -37.53% |
| Debt/Equity | 15.71 |
| Recommendation | None |
| Analyst Target | $26.86 |
| Analysts | 7 |
| Indexes | NASDAQ |
Technical Indicators
| RSI (14) | 64.1 |
| Beta | - |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | $24.33 |
| 52-Week Low | $10.85 |
| 50-Day Avg | $18.92 |
| 200-Day Avg | $17.79 |
| Avg Volume | 320.5K |
| Volume | 316.6K |
Performance Analysis
BULLISHCBLL shows predominantly bullish signals based on its fundamentals and technicals.
Recent News
Last updated: Jul 02, 2026 13:02 UTC
Back to Screener Export Report